Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

China Releases New Policies To Welcome More Foreign Investment

This article was originally published in PharmAsia News

Executive Summary

SHANGHAI - China's State Council released April 13 new guidelines that allow more foreign investment in China that promise a better environment for overseas investment, drawing some relief for industry associations that consider recent policy moves as protectionist and that they say stifle cross-border innovation

You may also be interested in...



Government Funding Accelerates Venture Interest In China

HONG KONG - The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns

Government Funding Accelerates Venture Interest In China

HONG KONG - The growth in available government funding for pharmaceutical companies in China is creating a snowball of investment from domestic and multinational pharma companies more willing to overcome intellectual property concerns

China Gaining Attention From EU Companies, But Regulatory Risks Raise Concerns

SHANGHAI - Most of the European companies operating in China are optimistic about the potential of China's growth and plan to increase their investments, local workforce and expand their R&D centers in China, according to a business confidence survey conducted by the European Chamber of Commerce China

Related Content

UsernamePublicRestriction

Register

SC074565

Ask The Analyst

Please Note: Click here for more information on the Ask the Analyst service.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel